Reaction Details Report a problem with these data
Target
Transmembrane and immunoglobulin domain-containing 3
Ligand
BDBM50096295
Substrate
n/a
Ki
>10000±n/a nM
Comments
PDSP_2564
Citation
 van Galen, PJ; van Bergen, AH; Gallo-Rodriguez, C; Melman, N; Olah, ME; IJzerman, AP; Stiles, GL; Jacobson, KA A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol 45:1101-11 (1994) [PubMed] 
Target
Name:
Transmembrane and immunoglobulin domain-containing 3
Synonyms:
ADENOSINE A3 | ADORA3 | Adora3 protein
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25707.75
Organism:
RAT
Description:
Q4V8H0
Residue:
232
Sequence:
MEPLLLLSLALFSDAMVMDEKVKSGVELDTASAICNYDAHYKDHTKYWCRGYFRDSCNIIAFTPNSSNRVALKDTGDQLIITVSCLVKEDTGWYWCGIQRDFARDDMDFTKLIVTDNREDRANGLSPGTSGNRTRSCKTSKAVQKAEGSRMSILIVCVLISGLGIIFLISHMSRGRRSQRNRGVTGKSINRNPQASQAPSMVSIPLTVLPKVPRQNGQQKALQWTGNATKTG
  
Inhibitor
Name:
BDBM50096295
Synonyms:
Uridine | Uridine dinucleoside 5'-polyphosphate analogue | hydrogen ({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate
Type:
Small organic molecule
Emp. Form.:
C9H12N2O12P2
Mol. Mass.:
402.1464
SMILES:
OC1C(O)C(OC1COP([O-])(=O)OP(O)([O-])=O)n1ccc(=O)[nH]c1=O
Structure:
Search PDB for entries with ligand similarity: